HSB-13

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHSB-13
Drug Alias Namenerve-degenerative disease therapy (EncephRx)HSB-13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSouthern Methodist University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEncephRxUniversity Of Texas SystemSouthern Methodist University
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A